ArticleThe Journal of clinical investigation2024

Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models.

Jezabel Rodriguez-Blanco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.